Vicki Bonke-Thallas
PO Box 6492, St Kilda Rd
Melbourne, VIC 8008, Australia
Melbourne, VIC 8008, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Targeted deletion of nicotinamide adenine dinucleotide phosphate oxidase 4 from proximal tubules is dispensable for diabetic kidney disease development.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: September 09, 2020
Processed foods drive intestinal barrier permeability and microvascular diseases.
Journal: Science advances
Published: August 31, 2020
Delineating a role for the mitochondrial permeability transition pore in diabetic kidney disease by targeting cyclophilin D.
Journal: Clinical science (London, England : 1979)
Published: July 31, 2019
Globally elevating the AGE clearance receptor, OST48, does not protect against the development of diabetic kidney disease, despite improving insulin secretion.
Journal: Scientific reports
Published: April 10, 2018
NADPH Oxidase Nox5 Accelerates Renal Injury in Diabetic Nephropathy.
Journal: Diabetes
Published: January 04, 2017
Mapping time-course mitochondrial adaptations in the kidney in experimental diabetes.
Journal: Clinical science (London, England : 1979)
Published: November 26, 2015
Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Journal: Diabetologia
Published: July 06, 2015
AT2R agonist, compound 21, is reno-protective against type 1 diabetic nephropathy.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: January 21, 2015
Last Updated: 09/26/2026